A phase 4, multicenter, cluster randomized, open-label, intervention versus
usual care, controlled study on the effect of emergency department initiation
of Airsupra on asthma outcomes
The study is a randomized controlled trial on the effect of emergency department initiation of Airsupra on acute asthma "recurrence" at 3 months and other related outcomes (acute asthma relapse, asthma control).
Study ID: 5048
NCT Number: NCT07166939
Principal Investigator: Christopher Sampson, MD
Department: Emergency Medicine
Eligibility: Both men and women 18 years old to 54 years old. Does not accept healthy volunteers.
For questions about this study, please contact:
ClinicalTrialsInterest@health.missouri.edu(573) 882-7026